Clinical Trial Update: Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the blood sugar-lowering effects of Biphasic Insulin Aspart 30 and Insulin Glargine, both used with metformin and glimepiride, in Chines…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Glimepiride (glimepiride)
• Insulin Glargine (insulin glargine)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2012-07-09